Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
about
The role of intensity modulated radiotherapy in gynecological radiotherapy: Present and futureHematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective.Whole pelvic helical tomotherapy for locally advanced cervical cancer: technical implementation of IMRT with helical tomotherapy.Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?A prospective phase II study of magnetic resonance imaging guided hematopoietical bone marrow-sparing intensity-modulated radiotherapy with concurrent chemotherapy for rectal cancer.Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer.Volumetric modulated arc therapy (VMAT) in the combined modality treatment of anal cancer patientsDosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer.A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy.Impact of acute hematological toxicity on treatment interruptions during cranio-spinal irradiation in medulloblastoma: a tertiary care institute experience.Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional dataExternal beam techniques to boost cervical cancer when brachytherapy is not an option-theories and applicationsA dosimetric analysis of volumetric-modulated arc radiotherapy with jaw width restriction vs 7 field intensity-modulated radiotherapy for definitive treatment of cervical cancer.Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy.Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.Fat composition changes in bone marrow during chemotherapy and radiation therapy.Spatial mapping of functional pelvic bone marrow using FLT PET.Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer.Association between bone marrow dosimetric parameters and acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy: comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapComparison of conformal and intensity modulated radiation therapy techniques for treatment of pelvic tumors. Analysis of acute toxicityDosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis.SmartArc-based volumetric modulated arc therapy for endometrial cancer: a dosimetric comparison with helical tomotherapy and intensity-modulated radiation therapyHow well do elderly patients with cervical cancer tolerate definitive radiochemotherapy using RapidArc? Results from an institutional audit comparing elderly versus younger patients3'-deoxy-3'-[¹⁸F]fluorothymidine PET quantification of bone marrow response to radiation dose.Long-term follow-up results of simultaneous integrated or late course accelerated boost with external beam radiotherapy to vaginal cuff for high risk cervical cancer patients after radical hysterectomy.Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy.Bone marrow sparing in intensity modulated proton therapy for cervical cancer: Efficacy and robustness under range and setup uncertainties.IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer CenterIntensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume hHematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer.Helical tomotherapy provides efficacy similar to that of intensity-modulated radiation therapy with dosimetric benefits for endometrial carcinoma.Modeling early haematologic adverse events in conformal and intensity-modulated pelvic radiotherapy in anal cancer.RapidArc radiotherapy for whole pelvic lymph node in cervical cancer with 6 and 15 MV: a treatment planning comparison with fixed field IMRT.[(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients.The role of PET/CT in cervical cancerClinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy.Does initial 45Gy of pelvic intensity-modulated radiotherapy reduce late complications in patients with locally advanced cervical cancer? A cohort control study using definitive chemoradiotherapy with high-dose rate brachytherapy.Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.
P2860
Q26829528-9C38034B-021D-4C5C-9766-4E65A81A3E48Q30235359-8898470B-8E1C-4627-AD4D-0D19CBAD8FAFQ33387475-C9D682D1-26F4-4D89-AAAF-5B2191E15B1BQ33398380-DC74DC9B-5700-41B2-B070-93E586F21518Q33422634-C02DD076-EB3B-4EBE-98D7-1158C8FE3161Q33424898-6BC94423-8526-4C53-9B34-C9E710CE4A20Q33427911-DF9FCADB-7EA0-472F-85D8-DBC3633D1B80Q33428648-B9259226-113C-437C-891F-63EC2EA52B92Q33429717-4E302D10-164A-43FC-88E8-A795D427D95FQ33431168-2721C7AF-3ED2-4C1A-8183-C0474B82929FQ33432469-66AB5D99-F55B-40E3-863B-CE9E9DC9AE3AQ33442381-F61CBDF1-652D-460A-9D9A-4C36AD441982Q33578833-CD15D348-3876-40F8-B00E-6329EFAD270DQ33747597-465F9924-7239-44A6-A823-C079AEE9F362Q33823328-30CE23F1-57D5-4F8F-A48E-2DB851E11174Q33889360-46C225BA-8CB9-4580-8E61-DF275C8542DFQ34009168-B5F7EE60-223B-4848-974B-A48D6AAD831AQ34156572-B6E5D7C8-E943-48A4-8AEA-BEBC847610B4Q34169627-269E1BF9-8521-4DD5-B3D7-94AC23F66EBAQ34246244-A6A53D7A-DC51-497A-91FC-A1655718B066Q34434263-C39349C2-A391-4AAA-8DA7-BB80DD26B141Q34439277-1528483B-072B-4560-A248-83ACEA435C99Q34487033-871D4CC5-91AC-4877-A3B7-91A6FDD37ECBQ34493985-EB5FF41A-9FA6-4F45-9A12-079764AE409BQ34680633-F34D793A-2B14-4346-A0F9-B24A678A8F99Q35118693-DC343035-EAB0-49C7-A7A2-B91BDBD79133Q35425510-7D287C9D-FE3C-4D3E-833B-EFD095D115C1Q35815373-4A63F4F7-B152-41B9-8231-014BE7EF1D40Q35868207-C944971C-6A93-49C3-8F97-6599479297BAQ35927962-4AD4D8C6-2D3A-48AC-9938-CF594FF64086Q36010000-3C36DE7C-E09D-4D07-8088-04C541B9DE0FQ36067677-1702F891-6151-4051-8E90-ACD25E916C09Q36296947-BA2621F9-A794-4E11-ABB7-C1A29AFE57D7Q36369579-2CE42B1E-10E6-43E6-9D75-25D6F87B156DQ36499999-7F01B9BA-155C-4BCB-AEAA-2DF42E3579B3Q36609751-2F7BC02E-F06D-46AC-9A08-CD2A279CEB09Q36637204-4F762FA4-B5B8-458B-946C-DEE0EB726CECQ36770157-9263263A-9EC5-45C9-B18C-62E0AF3C1C9AQ36951099-5F9D6780-89C5-423C-B12A-4867B19394F2Q37013997-ACF48366-349E-4584-8F12-9FC5E8B2D939
P2860
Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Dosimetric predictors of acute ...... modulated pelvic radiotherapy.
@ast
Dosimetric predictors of acute ...... modulated pelvic radiotherapy.
@en
type
label
Dosimetric predictors of acute ...... modulated pelvic radiotherapy.
@ast
Dosimetric predictors of acute ...... modulated pelvic radiotherapy.
@en
prefLabel
Dosimetric predictors of acute ...... modulated pelvic radiotherapy.
@ast
Dosimetric predictors of acute ...... modulated pelvic radiotherapy.
@en
P2093
P1476
Dosimetric predictors of acute ...... modulated pelvic radiotherapy.
@en
P2093
Arno J Mundt
Jean A Hurteau
Joel D Kochanski
John C Roeske
Josh J Haslam
Neil Mehta
S Diane Yamada
Yvonne C Collins
P304
P356
10.1016/J.IJROBP.2006.03.018
P407
P577
2006-06-06T00:00:00Z